Close Menu

More articles about Research & Discovery

The new initiative, called MEGA+, will extend the process of genomic data sharing to all medical data, including electronic health records and imaging files.

At the WIN Symposium, a researcher from Sheba Medical Center discussed ongoing efforts to develop a 22-gene signature for predicting brain metastasis in NSCLC.

The company said that it will use the funds to commercialize its IsoLight platform for use in quality control and guidance of CAR T therapy.

APEX-seq builds on a proteomic labelling technique and offers a new spatial genomics tool for looking at the life of transcripts within the cell.

So-called DNA microscopy is the latest entrant to the rapidly growing spatial genomics field that combines molecular analysis with imaging.

The researchers found that dark regions impact more than 700 protein-coding genes and also identified a novel mutation in a known Alzheimer's disease gene.

The new grant will be used to conduct whole-exome sequencing on 1,000 children participating in an autism spectrum disorder study for the purposes of biomarker development.

Genome-wide association analyses spanning 26 phenotypes in diverse populations revealed new risk variants and population-specific contributions for known SNPs.

The agreement follows a number of other distribution deals Bioké has signed in recent months including ones with Omni Life Science, Syntec, and Namocell.

The San Diego-based firm emerged from stealth mode with a plan to develop technologies to improve the quality and reduce the cost of genetic analysis.

Scientists from the UK and China discussed two new NIPTs that include single-gene disorders and a study to estimate disease recurrence risk in families.

New instrumentation, reagents, and methods, as well as increasing interest in small and single-cell samples, could prove a boon for the technology.

The Genes for Good Project has engaged 80,000 Facebook users via its online application and genotyped 27,000 people to date.

Regeneron is covering the cost of the sequencing and genotyping, and both partners will have access to the data for research purposes.

The researchers are aiming to find molecular signatures in blood that identify previous exposures to materials associated with weapons of mass destruction.

The firm is in the midst of a clinical trial called NOVA to compare its circulating-tumor DNA-based Colvera test to DiaSorin's carcinoembryonic antigen assay.

Harvard and Brigham and Women's Hospital researchers will help guide Sanford in using and interpreting data collected through its Sanford Chip pharmacogenomic test.

Consenting participants will have their deidentified sequence data used for research and will also have the chance to learn if they have clinically actionable results.

The partners are both "investing heavily" in the study and will have access to the data and to new technologies and interventions.

The Singapore-based firm plans to use its single-cell RNA and protein assay to help optimize the production of CAR T cells and guide their use in patients.

Pages

The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.

Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.

NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.

In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.